Todd J, Fishaut M, Kapral F, et al: Toxic shock syndrome associated with phage group I staphylococci . Lancet 1978;;2:1116-1118.
Schumer W: Steroids in the treatment of clinical septic shock . Ann Surg 1976;;184:333-341.
Quinn S, Snader TC: Corticosteroid therapy for septic shock: Review and analysis . Drug Intell Clin Pharm 1980;;14:247-251.
Wiesenthal AM, Ressman M, Caston SA, et al: Incidence of hospitalized toxic shock syndrome in defined populations, 1970-1980 . Presented at the 22nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Miami, Oct 5, 1982 .
Shands KN, Schmid GP, Dan BB, et al: Toxic shock syndrome in menstruating women . N Engl J Med 1980;;303:1436-1442.
Hollander M, Wolfe DA: Non-parametric Statistical Methods . New York, John Wiley & Sons Inc, 1973;, pp 68-75.
Swinscow TDV: Statistics at Square One . Bath, England, Dawson & Goodall Ltd, The Mendip Press, 1976;, p 54.
Klastersky J, Cappel R, Debusscher L: Effectiveness of betamethasone in management of severe infections . N Engl J Med 1971;;284:1248-1250.
Todd JK: Toxic shock syndrome—scientific uncertainty and the public media . Pediatrics 1981;;67:921-923.
Chesney PJ, Crass BA, Polyak MB, et al: Toxic shock syndrome: Management and long-term sequelae . Ann Intern Med 1982;;96(pt
(2)
):847-851.
Horwitz RI, Feinstein AR: Methodologic standards and contradictory results in case-control research . Am J Med 1979;;66:556-564.
Weitzman S, Berger S: Clinical trial design in studies of corticosteroids for bacterial infections . Ann Intern Med 1974;;81:36-42.
Goldfarb RD, Glenn TM: Regulation of lysosomal membrane stabilization via cyclic nucleotides and prostaglandins: The effects of steroids and indomethacin , in Lefer AM, Schumer W (eds): Molecular and Cellular Aspects of Shock and Trauma . New York, Alan R Liss Inc, 1983;, pp 147-166.
Hammerschmidt DE, White JG, Craddock PR, et al: Corticosteroids inhibit complement-induced granulocyte aggregation: A possible mechanism for their efficacy in shock states . J Clin Invest 1979;;63:798.
Kapral FA: Epidermal toxin production by Staphylococcus aureus strains from patients with toxic shock syndrome . Ann Intern Med 1982;;96(pt
(2)
):972-974.
Schlievert PM, Shands KN, Dan BB, et al: Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic shock syndrome . J Infect Dis 1981;;143:509-516.
Bergdoll MS, Crass BA, Reiser RF, et al: A new staphylococcal enterotoxin, enterotoxin F, associated with toxic shock syndrome Staphylococcus aureus isolates . Lancet 1981;;1:1017-1021.
Cohen ML, Falkow S: Protein antigens from Staphylococcus aureus strains associated with toxic shock syndrome . Science 1981;;211:842-844.
Barbour AG: Vaginal isolates of Staphylococcus aureus associated with toxic shock syndrome . Infect Immun 1981;;33:442-449.
Todd JK, Franco-Buff A, Lawellin DW, et al: Phenotypic distinctiveness of Staphylococcus aureus strains associated with toxic shock syndrome . Infect Immun 1984;;45:339-344.
Todd JK: Pathogenesis of toxic shock syndrome: Clinical-bacteriological correlates . Surv Synth Path Res 1984;;3:63-72.
Peterson PK, Schlievert PM, Conroy W, et al: Protection against staphylococcal pyrogenic exotoxin type C-enhanced endotoxin lethality with methylprednisolone and IgG . J Infect Dis 1983;;147:358-359.
Lawellin DW, Franco-Buff A, Vasil ML, et al: Effect of hydrocortisone on proteolytic and hemolytic activities of staphylococcal isolates from toxic shock syndrome . Presented at the Annual Meeting of the American Society for Microbiology, New Orleans, March 10, 1983 .
Davis JP, Osterholm MT, Helms CM, et al: Tri-state toxic shock syndrome study, II. Clinical and laboratory findings . J Infect Dis 1982;; 145:441-448.